{"id":"W4383618500","doi":"10.1016/j.jtha.2023.06.036","title":"Warfarin faring better: vitamin K antagonists beat rivaroxaban and apixaban in the INVICTUS and PROACT Xa trials","year":2023,"lang":"en","type":"review","venue":"Journal of Thrombosis and Haemostasis","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University; Population Health Research Institute","funders":"Heart and Stroke Foundation of Canada","keywords":"Apixaban; Rivaroxaban; Warfarin; Medicine; Vitamin K antagonist; Internal medicine; Pharmacology; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002488464,0.001001213,0.006507166,0.001596384,0.0002289703,0.001787911,0.001316806,0.001698472,0.006195911],"category_scores_gemma":[0.005323119,0.0004470054,0.003249951,0.002413112,0.0003413992,0.001153236,0.0006548895,0.002479091,0.0005477053],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009501717,"about_ca_system_score_gemma":0.001745546,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002543435,"about_ca_topic_score_gemma":0.009202446,"domain_scores_codex":[0.9989906,0.0003685461,0.0002885012,0.0001123739,0.0001685964,0.00007129338],"domain_scores_gemma":[0.9976554,0.001608703,0.0004818458,0.00002930604,0.0001356044,0.00008907684],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.005780318,0.00009815778,0.0005717224,0.326967,0.01739599,0.0001592937,0.0001437868,0.000408478,0.0007289033,0.00133422,0.02923031,0.6171818],"study_design_scores_gemma":[0.02031794,0.001832356,0.01326673,0.3566126,0.1438628,0.001186097,0.0004686441,0.0006075435,0.0009111802,0.007568392,0.4531307,0.0002349904],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002161311,0.9992502,0.00002999489,0.000208171,0.00008899048,0.00001170378,0.00004400083,0.000003508773,0.000147264],"genre_scores_gemma":[0.003674903,0.9950924,0.0001905141,0.0006275905,0.0001680204,0.00002530215,0.000074566,0.000003655682,0.0001430876],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006507166,"threshold_uncertainty_score":0.02072734,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.501218852969253,"score_gpt":0.4922110053701738,"score_spread":0.009007847599079188,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}